PSOGI World News - July 2025 Newsletter

A quarterly newsletter with the latest news, views and announcements from Peritoneal Surface Oncology Group International (PSOGI)

Led by pioneering surgical oncologist Dr. Paul Sugarbaker, PSOGI is a collaboration of experts from around the world on the treatment of peritoneal cancer and is dedicated to improving treatment and survival of patients with peritoneal metastases. While PSOGI World News is a quarterly publication primarily intended for healthcare professionals, this issue offers valuable insights for patients and caregivers navigating these complex cancers.

We are proud to share their quarterly newsletter.

---

The Summer 2025 edition of PSOGI World News highlights the global momentum behind peritoneal surface oncology with updates from leaders, institutions, and regions around the world. Included in this issue:

Presidential Perspective

Dr. Jesus Esquivel, PSOGI President, outlines the organization’s strategic focus: enhancing international collaboration, advancing education, and preparing for the 2026 PSOGI Congress in Hong Kong—a key milestone for the global peritoneal cancer community.

Regional Update: The Americas

Dr. Laura Lambert highlights increased engagement with national surgical societies across North and South America. She emphasizes the importance of supporting young surgeons and integrating PSOGI’s mission into national education platforms.

Spotlight on Argentina

Dr. Leandro Siragusa reports significant advancements in Argentina’s approach to peritoneal metastases, including expanded access to treatment and a vision for regional training hubs to support Latin American surgeons.

Africa’s Emerging Efforts

Dr. Peter Harris provides an overview of efforts to grow peritoneal cancer awareness and increase HIPEC availability across the African continent, despite ongoing challenges related to healthcare infrastructure and access.

India and Southeast Asia

Dr. Arvind Kumar details the growing volume of cytoreductive surgeries in India and neighboring regions, attributing progress to better multidisciplinary teamwork, institutional training, and the collection of local outcome data.

PSOGI at ASCO 2025

PSOGI had a strong presence at ASCO 2025, sharing research, participating in global discussions, and strengthening its position as a leader in collaborative oncology research focused on peritoneal surface malignancies.

The Summer 2025 PSOGI newsletter features upcoming events, key research publications, and messages from regional coordinators. As always, PSOGI World News offers a global lens on the innovations, challenges, and shared commitment to improving outcomes for patients with peritoneal surface malignancies.

Read the full July 2025 issue of PSOGI World News here:

Read More

If you have questions about your diagnosis and/or treatment options, speak with your doctor to determine the best plan for you.